General MedicationsINJECTIONStandard
ENZEEVU
AFLIBERCEPT-ABZV
Standard Dose
2MG(0.05ML of 40MG/ML)
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview ENZEEVU is listed in Drugs@FDA under application 761382 (BLA).
Review priority: STANDARD Marketing status: Prescription Active ingredient AFLIBERCEPT-ABZV Form and strength INJECTABLE;INJECTION - 2MG(0.05ML of 40MG/ML) Sponsor SANDOZ INC Submission history Latest submission status date: 2026-02-12 00:00:00.
Structured Monograph
Clinical summary
Approval overview ENZEEVU is listed in Drugs@FDA under application 761382 (BLA). Review priority: STANDARD Marketing status: Prescription Active ingredient AFLIBERCEPT-ABZV Form and strength INJECTABLE;INJECTION - 2MG(0.05ML of 40MG/ML) Sponsor SANDOZ INC Submission history Latest submission status date: 2026-02-12 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.